Elsevier

Brain Research

Volume 698, Issues 1–2, 6 November 1995, Pages 204-208
Brain Research

DOI, a 5-HT2A/2C receptor agonist, potentiates amphetamine-induced dopamine release in rat striatum

https://doi.org/10.1016/0006-8993(95)00865-NGet rights and content

Abstract

The effects of (±)-DOI (1-(2,5-dimethoxy-4-iodophenyl)-aminopropane) hydrochloride, a mixed 5-HT2A/2C receptor agonist, on the release of dopamine (DA) following d-amphetamine sulfate (AMP) or a DA D2 autoreceptor selective dose of (−)-apomorphine hydrochloride (APO), were investigated in rat striatum (STR) and nucleus accumbens (NAC), using in vivo microdialysis. AMP (1.0 mg/kg, s.c.) produced marked increases in extracellular DA levels in both the STR and the NAC whereas DOI (2.5 mg/kg, i.p.) alone had no significant effect on extracellular DA levels in either region. Pretreatment with DOI 30 min prior to AMP, further enhanced the AMP-induced increase in striatal extracellular DA levels. On the other hand, DOI pretreatment attenuated the APO (50 μg/kg, s.c.)-induced decrease in extracellular DA levels in the STR. Pretreatment with DOI did not affect the ability of either AMP or APO to modulate extracellular DA levels in the NAC. These results provide further evidence that 5-HT2A/2C receptors modulate the release mechanisms of DA in the STR. Possible mechanisms are discussed.

Referencess (25)

  • ErikssonE. et al.

    The effect of amperozide on uptake and release of3H-dopamine in vitro from perfused rat striatal and limbic brain areas

    Pharmacol. Toxicol.

    (1990)
  • IchikawaJ. et al.

    Amperozide, a novel antipsychotic drug, inhibits the ability of d-amphetamine to increase dopamine release in vivo in rat striatum and nucleus accumbens

    J. Neurochem.

    (1992)
  • Cited by (73)

    • Serotonin/dopamine interaction: Electrophysiological and neurochemical evidence

      2021, Progress in Brain Research
      Citation Excerpt :

      This effect suggests the existence of 5-HT2A receptor-dependent inhibitory control upon cortical DA release, a 5-HT2C receptor-dependent effect (see below) or a 5-HT2A receptor-independent mechanism (Ichikawa et al., 2001b; Liegeois et al., 2002). Moreover, DOI, without an effect by itself, potentiated amphetamine or MDMA-induced DA efflux in the mPFC, NAc and striatum (Gudelsky et al., 1994; Ichikawa and Meltzer, 1995a; Kuroki et al., 2003). Compelling evidence from biochemical and electrophysiological studies indicates that 5-HT2A receptors may modulate the impulse flow-dependent and independent release of DA through mechanisms involving regulation of either DA synthesis or DA neuron firing rate (Gudelsky et al., 1994; Palfreyman et al., 1993; Schmidt and Fadayel, 1996; Schmidt et al., 1992b).

    • Serotonergic imaging in Parkinson's disease

      2021, Progress in Brain Research
    View all citing articles on Scopus
    View full text